Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Adverse cutaneous drug reaction to alendronate.

× No keyword cloud information.

7 in total

Review 1. Screening, diagnosis and treatment of osteoporosis: a brief review.

Authors: Roberto Bernabei; Anna Maria Martone; Elena Ortolani; Francesco Landi; Emanuele Marzetti
Journal: Clin Cases Miner Bone Metab Date: 2014-09

2. Cutaneous side effects of antiosteoporosis treatments.

Authors: Philippe Musette; Jean-Marc Kaufman; René Rizzoli; Patrice Cacoub; Maria Louisa Brandi; Jean-Yves Reginster
Journal: Ther Adv Musculoskelet Dis Date: 2011-02 Impact factor: 5.346

Review 3. Safety of long-term bisphosphonate therapy for the management of osteoporosis.

Authors: E Michael Lewiecki
Journal: Drugs Date: 2011-04-16 Impact factor: 9.546

4. Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.

Authors: J-J Body; P Bergmann; S Boonen; J-P Devogelaer; E Gielen; S Goemaere; J-M Kaufman; S Rozenberg; J-Y Reginster
Journal: Osteoporos Int Date: 2012-02-04 Impact factor: 4.507

Review 5. Treatment of osteoporosis: recognizing and managing cutaneous adverse reactions and drug-induced hypersensitivity.

Authors: P Musette; M L Brandi; P Cacoub; J M Kaufman; R Rizzoli; J-Y Reginster
Journal: Osteoporos Int Date: 2009-11-17 Impact factor: 5.071

6. Zoledronic Acid-Induced Interface Dermatitis.

Authors: Farah Succaria; Mary Collier; Meera Mahalingam
Journal: Am J Dermatopathol Date: 2015-12 Impact factor: 1.533

7. Predictive values of diagnostic codes for identifying serious hypocalcemia and dermatologic adverse events among women with postmenopausal osteoporosis in a commercial health plan database.

Authors: Florence T Wang; Fei Xue; Yan Ding; Eva Ng; Cathy W Critchlow; David D Dore
Journal: BMC Health Serv Res Date: 2018-04-10 Impact factor: 2.655

7 in total